SeaStar Medical Holding ICU
NASDAQ ICU
$3.35 +0.01 (+0.30%)
At close: Aug 21, 2026 · 4:00 PM EDT

SeaStar Medical Holding (ICU) Liabilities and Shareholders Equity (2020 - 2026)

SeaStar Medical Holding's (ICU) quarterly Liabilities and Shareholders Equity came in at $11.3 million in Q1 2026, down 20.68% YoY from $14.2 million in Q1 2025, and down 20.45% on a QoQ basis from $14.2 million in Q4 2025.

SeaStar Medical Holding (ICU) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

SeaStar Medical Holding (ICU) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $11.3 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 20.68% year-over-year to $11.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.3 million (up 82.99% YoY) and the FY2025 annual result came in at $14.2 million, up 201.23% from the prior year.
  • Liabilities and Shareholders Equity fell to $11.3 million in Q1 2026, from $14.2 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $107.3 million in Q3 2022 to a low of $2.5 million in Q3 2023.
  • A 5-year average of $24.6 million and a median of $7.7 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity surged 403.81% — and 2023, when it tumbled 97.66%.
  • Tracing ICU's Liabilities and Shareholders Equity over 5 years: stood at $3.0 million in 2022, then grew by 15.64% to $3.5 million in 2023, then jumped by 33.79% to $4.7 million in 2024, then jumped by 201.23% to $14.2 million in 2025, then dropped by 20.45% to $11.3 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $11.3 million (Q1 2026), $14.2 million (Q4 2025), and $15.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 10.03 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 10.96 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 9.18 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 5.56 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 25.60 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 2.10 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 19.82 Bn
10 SeaStar Medical Holding 13.68 Mn 6.68 Mn 561,000.00 8.65 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 8.65 Mn
Mar 31, 2026 11.26 Mn
Dec 31, 2025 14.16 Mn
Sep 30, 2025 15.50 Mn
Jun 30, 2025 8.40 Mn
Mar 31, 2025 14.20 Mn
Dec 31, 2024 4.70 Mn
Sep 30, 2024 4.59 Mn
Jun 30, 2024 3.47 Mn
Mar 31, 2024 7.74 Mn
Dec 31, 2023 3.51 Mn
Sep 30, 2023 2.51 Mn
Jun 30, 2023 2.60 Mn
Mar 31, 2023 3.65 Mn
Dec 31, 2022 3.04 Mn
Sep 30, 2022 107.34 Mn
Jun 30, 2022 105.95 Mn
Mar 31, 2022 105.96 Mn
Dec 31, 2021 603,000.00
Sep 30, 2021 106.20 Mn